These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21653795)

  • 1. Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin-dependent diabetes mellitus in the Genetically at Risk (TRIGR).
    Knip M; Virtanen SM; Becker D; Dupré J; Krischer JP; Åkerblom HK;
    Am J Clin Nutr; 2011 Dec; 94(6 Suppl):1814S-1820S. PubMed ID: 21653795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial.
    Knip M; Åkerblom HK; Becker D; Dosch HM; Dupre J; Fraser W; Howard N; Ilonen J; Krischer JP; Kordonouri O; Lawson ML; Palmer JP; Savilahti E; Vaarala O; Virtanen SM;
    JAMA; 2014 Jun; 311(22):2279-87. PubMed ID: 24915259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up.
    ; Akerblom HK; Krischer J; Virtanen SM; Berseth C; Becker D; Dupré J; Ilonen J; Trucco M; Savilahti E; Koski K; Pajakkala E; Fransiscus M; Lough G; Bradley B; Koski M; Knip M
    Diabetologia; 2011 Mar; 54(3):627-33. PubMed ID: 21153533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Concentrations of Immunoglobulin G Against Cow Milk Proteins and Frequency of Cow Milk Consumption Are Associated With the Development of Islet Autoimmunity and Type 1 Diabetes-The Trial to Reduce Insulin-dependent Diabetes Mellitus (IDDM) in the Genetically at Risk (TRIGR) Study.
    Niinistö S; Cuthbertson D; Miettinen ME; Hakola L; Nucci A; Korhonen TE; Hyöty H; Krischer JP; Vaarala O; Knip M; Savilahti E; Virtanen SM;
    J Nutr; 2024 Aug; 154(8):2493-2500. PubMed ID: 38906178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruitment and retention of participants for an international type 1 diabetes prevention trial: a coordinators' perspective.
    Franciscus M; Nucci A; Bradley B; Suomalainen H; Greenberg E; Laforte D; Kleemola P; Hyytinen M; Salonen M; Martin MJ; Catte D; Catteau J;
    Clin Trials; 2014 Apr; 11(2):150-8. PubMed ID: 24216218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avoidance of Cow's Milk-Based Formula for At-Risk Infants Does Not Reduce Development of Celiac Disease: A Randomized Controlled Trial.
    Hyytinen M; Savilahti E; Virtanen SM; Härkönen T; Ilonen J; Luopajärvi K; Uibo R; Vaarala O; Åkerblom HK; Knip M;
    Gastroenterology; 2017 Oct; 153(4):961-970.e3. PubMed ID: 28687275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial.
    ; Knip M; Åkerblom HK; Al Taji E; Becker D; Bruining J; Castano L; Danne T; de Beaufort C; Dosch HM; Dupre J; Fraser WD; Howard N; Ilonen J; Konrad D; Kordonouri O; Krischer JP; Lawson ML; Ludvigsson J; Madacsy L; Mahon JL; Ormisson A; Palmer JP; Pozzilli P; Savilahti E; Serrano-Rios M; Songini M; Taback S; Vaarala O; White NH; Virtanen SM; Wasikowa R
    JAMA; 2018 Jan; 319(1):38-48. PubMed ID: 29297078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary intervention in infancy and later signs of beta-cell autoimmunity.
    Knip M; Virtanen SM; Seppä K; Ilonen J; Savilahti E; Vaarala O; Reunanen A; Teramo K; Hämäläinen AM; Paronen J; Dosch HM; Hakulinen T; Akerblom HK;
    N Engl J Med; 2010 Nov; 363(20):1900-8. PubMed ID: 21067382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study.
    Akerblom HK; Virtanen SM; Ilonen J; Savilahti E; Vaarala O; Reunanen A; Teramo K; Hämäläinen AM; Paronen J; Riikjärv MA; Ormisson A; Ludvigsson J; Dosch HM; Hakulinen T; Knip M;
    Diabetologia; 2005 May; 48(5):829-37. PubMed ID: 15838685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR).
    TRIGR Study Group
    Pediatr Diabetes; 2007 Jun; 8(3):117-37. PubMed ID: 17550422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood.
    Luopajärvi K; Savilahti E; Virtanen SM; Ilonen J; Knip M; Akerblom HK; Vaarala O
    Pediatr Diabetes; 2008 Oct; 9(5):434-41. PubMed ID: 18503496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk.
    Nucci AM; Virtanen SM; Cuthbertson D; Ludvigsson J; Einberg U; Huot C; Castano L; Aschemeier B; Becker DJ; Knip M; Krischer JP;
    Diabetologia; 2021 Apr; 64(4):826-835. PubMed ID: 33474583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of extensively hydrolyzed casein vs. conventional formula on the risk of asthma and allergies: The TRIGR randomized clinical trial.
    Virtanen SM; Cuthbertson D; Couluris M; Savilahti E; Knip M; Krischer JP;
    Pediatr Allergy Immunol; 2021 May; 32(4):670-678. PubMed ID: 33438271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and compliance in a nutritional primary prevention trial in infants at increased risk for type 1 diabetes.
    Virtanen SM; Bärlund S; Salonen M; Savilahti E; Reunanen A; Paronen J; Hämäläinen AM; Ilonen J; Teramo K; Erkkola M; Ormisson A; Einberg Ü; Riikjärv MA; Ludvigsson JG; Knip M; Åkerblom HK;
    Acta Paediatr; 2011 Apr; 100(4):557-64. PubMed ID: 21114527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term effects of feeding hydrolyzed protein infant formulas on growth at < or = 6 y of age: results from the German Infant Nutritional Intervention Study.
    Rzehak P; Sausenthaler S; Koletzko S; Reinhardt D; von Berg A; Krämer U; Berdel D; Bollrath C; Grübl A; Bauer CP; Wichmann HE; Heinrich J;
    Am J Clin Nutr; 2009 Jun; 89(6):1846-56. PubMed ID: 19369380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high-risk children: a randomized controlled trial.
    Lowe AJ; Hosking CS; Bennett CM; Allen KJ; Axelrad C; Carlin JB; Abramson MJ; Dharmage SC; Hill DJ
    J Allergy Clin Immunol; 2011 Aug; 128(2):360-365.e4. PubMed ID: 21696814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early infant feeding and type 1 diabetes.
    Savilahti E; Saarinen KM
    Eur J Nutr; 2009 Jun; 48(4):243-9. PubMed ID: 19263185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Infant Formula Type and Risk of Islet Autoimmunity in The Environmental Determinants of Diabetes in the Young (TEDDY) Study.
    Hummel S; Beyerlein A; Tamura R; Uusitalo U; Andrén Aronsson C; Yang J; Riikonen A; Lernmark Å; Rewers MJ; Hagopian WA; She JX; Simell OG; Toppari J; Ziegler AG; Akolkar B; Krischer JP; Virtanen SM; Norris JM;
    Diabetes Care; 2017 Mar; 40(3):398-404. PubMed ID: 28096222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants.
    Osborn DA; Sinn J
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003664. PubMed ID: 17054180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between family history, early growth and the risk of beta cell autoimmunity in children at risk for type 1 diabetes.
    Pacaud D; Nucci AM; Cuthbertson D; Becker DJ; Virtanen SM; Ludvigsson J; Ilonen J; Knip M;
    Diabetologia; 2021 Jan; 64(1):119-128. PubMed ID: 33026463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.